Integrated analysis supports efficacy and safety of G/P in chronic HCV with comorbidities and medications, suggesting broad applicability.
These pooled data support the efficacy, safety, and tolerability of G/P in participants with chronic HCV infection and comorbidities or who are on multiple concomitant medications.
No takes yet. Share an insight, caveat, or question.
Cooper et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: